With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...

Most pet insurance requires you to pay for the services upfront at your vet and then file a claim to be reimbursed afterward.

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

Innovative technology represents a breakthrough scientific achievement for one of the most common feline infectious diseases RAHWAY, N.J., September 24, 2024--(BUSINESS WIRE)--Merck Animal Health ...

is set to be available in veterinary clinics and hospitals across the United States this fall. NOBIVAC NXT FeLV is the first FeLV vaccine leveraging Merck's RNA-particle platform, similar to the ...

Merck’s ongoing pneumococcal vaccine development program is designed to provide options that address the specific needs of different populations, including infants and children, healthy adults ...

There is also growing global concern about antimicrobial resistance in agriculture and veterinary ... virus. Merck Animal ...

The global veterinary biologics market is on a robust growth trajectory, with its valuation expected to reach USD 13,140.6 ...

Vaccines – If your dog is not vaccinated ... are at a lower risk for developing cancer, according to a Merck Veterinary Manual study. In female dogs, for example, the more heat cycles she experiences ...

The vaccine is expected to be available at veterinary clinics and hospitals nationwide this fall. NOBIVAC NXT FeLV is the first and only feline leukemia virus vaccine built on Merck Animal Health’s ...